using VAMS to measure the alcohol abuse biomarker PEth
by James Rudge, PhD, Technical Director, Neoteryx | 6 min read A “Letter to the Editor” by Christophe P. Stove et al at Ghent University,...
using VAMS to measure the alcohol abuse biomarker PEth
using VAMS to measure drug level and renal function
monitoring mycotoxin exposure using VAMS
monitoring mycotoxin exposure using VAMS
clinical trial: bridging between VAMS and traditional samples
Inventor Spotlight: Mitra devices with VAMS for microsampling
Using LC-MS/MS to measure mAbs from VAMS extracts
ADVY NEW ITEM "Native Antigens"
Inventor Spotlight: Mitra devices with VAMS for microsampling
microsampling to investigate cytokines: Dr. Ben Herbert (pt. 2)
microsampling to investigate cytokines: Dr. Ben Herbert (pt.1 )
VAMS dried urine samples for measuring antimalarial levels
microsampling to map a pandemic: Kaitlyn Sadtler, PhD
microsampling in toxicology: biomarkers of drugs & alcohol: Dr. Christophe Stove & Dr. Katleen Van U
microsampling in proteomics, precision medicine: Jennifer Van Eyk, PhD
microsampling for patients on therapeutic drugs: Florian Lemaitre, PharmD, PhD
Brazil Registers Neoteryx’s Mitra Devices for Specimen Collection
VAMS method measures MEK1/2 inhibitor for PK studies
VAMS to measure cannabinoids in pediatric studies
Holmes Trial Verdict: Lessons Learned from the Fall of Theranos